Search

everythinglearnresearchcommunity

for

Search:↓

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

New compounds with carborane showed anti-androgen effects similar to flutamide.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

The vitamin D receptor helps maintain hair and bone health even without binding vitamin D.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Women with hair loss have more androgen receptors in certain hair follicles.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.